Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.42%
-0.09%
-2.69%
TMDX
TransMedics Group In
$121.58
Chart
69.15
77.12
78.67
133.63
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.42%
-0.09%
-2.69%
TMDX
TransMedics Group In
Current Price
$121.58
Login to view TransMedics Group In (TMDX) recommendation from the last 90 days from financial news and social media.
Chart
69.15
77.12
78.67
133.63
TMDX Latest Headlines
What Makes TransMedics (TMDX) a New Buy Stock. TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Thu May 15, 2025
Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?. TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.
Thu May 15, 2025
Is TransMedics Group Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?.
Tue May 13, 2025
Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now.
Tue May 13, 2025
TMDX Crosses Above Average Analyst Target. In recent trading shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $110.00 changing hands for $111.50/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade
Mon May 12, 2025
Investor Alert: Wolfspeed Driven Brands Holdings Hasbro and TransMedics: Johnson Fistel PLLP Investigates Claims on Behalf of Investors. SAN DIEGO May 09 2025 (GLOBE NEWSWIRE) -- Johnson Fistel PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: Wolfspeed Inc. (NYSE:) Driven Brands Holdings Inc. (NASDAQ:) Hasbro Inc. (NASDAQ:) and TransMedics Group Inc. (NASDAQ:).Wolfspeed Inc. (NYSE:)Johnson Fistel PLLP is investigating claims on
Sat May 10, 2025
Notable Friday Option Activity: TMDX ILMN FDX. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in TransMedics Group Inc (Symbol: TMDX) where a total of 16796 contracts have traded so far representing approximately 1.7 million underlying shares. That amounts to abo
Fri May 9, 2025
Why TransMedics Stock Is Skyrocketing Today. Shares of next-generation transplant technology platform TransMedics (NASDAQ: TMDX) were up 21% as of noon ET on Friday according to data provided by S&.P Global Market Intelligence.
Fri May 9, 2025
Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat.
Fri May 9, 2025
TransMedics Group GAAP EPS of $0.70 beats by $0.45 revenue of $143.5M beats by $20.11M.
Thu May 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TMDX Stock trends
TMDX Stock performance
TMDX Stock analysis
TMDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
